Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Akakura

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Future Oncology (London, England)|January 26, 2024
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in JapanKoichiro Akakura, Hiroji Uemura, Satoru Kawakami, et al.
European Urology|June 21, 2002
Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or olderHiroyoshi Suzuki, Koichiro Akakura, Takeshi Ueda, et al.
Anticancer Research|July 31, 2012
Biochemical failure after carbon ion radiotherapy for prostate cancerJun Shimazaki, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
International Journal of Clinical Oncology|June 29, 2004
Primary adrenal leiomyosarcoma with inferior vena cava thrombosisTomonori Kato, Tomonori Kato, Shinichi Sakamoto, et al.
Japanese Journal of Clinical Oncology|April 24, 2022
External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort studyTakanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa, et al.
The Journal of Urology|December 11, 2003
Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parametersHiroyoshi Suzuki, Koichiro Akakura, Tatsuo Igarashi, et al.
The Prostate|February 18, 2005
Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancerTakeshi Ueda, Akira Komiya, Hiroyoshi Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 22, 2003
Usefulness of diagnostic imaging in primary hyperparathyroidismKazuya Sekiyama, Koichiro Akakura, Kazuo Mikami, et al.
Plos One|June 25, 2015
Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation TherapyYoshito Hirata, Kai Morino, Koichiro Akakura, et al.
The Prostate|September 5, 2002
Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancerYoko Kawana, Tomohiko Ichikawa, Hiroyoshi Suzuki, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Future Oncology (London, England)|January 26, 2024
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in JapanKoichiro Akakura, Hiroji Uemura, Satoru Kawakami, et al.
European Urology|June 21, 2002
Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or olderHiroyoshi Suzuki, Koichiro Akakura, Takeshi Ueda, et al.
Anticancer Research|July 31, 2012
Biochemical failure after carbon ion radiotherapy for prostate cancerJun Shimazaki, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
International Journal of Clinical Oncology|June 29, 2004
Primary adrenal leiomyosarcoma with inferior vena cava thrombosisTomonori Kato, Tomonori Kato, Shinichi Sakamoto, et al.
Japanese Journal of Clinical Oncology|April 24, 2022
External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort studyTakanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa, et al.
The Journal of Urology|December 11, 2003
Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parametersHiroyoshi Suzuki, Koichiro Akakura, Tatsuo Igarashi, et al.
The Prostate|February 18, 2005
Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancerTakeshi Ueda, Akira Komiya, Hiroyoshi Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 22, 2003
Usefulness of diagnostic imaging in primary hyperparathyroidismKazuya Sekiyama, Koichiro Akakura, Kazuo Mikami, et al.
Plos One|June 25, 2015
Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation TherapyYoshito Hirata, Kai Morino, Koichiro Akakura, et al.
The Prostate|September 5, 2002
Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancerYoko Kawana, Tomohiko Ichikawa, Hiroyoshi Suzuki, et al.
Pageof 12